Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses

Journal of Immunology

Volumn 173, Issue 4, 2004, Pages 2855-2865

  Cignetti, Alessaadro ^a   Vallario, Antonella ^a,b   Roato, Ilaria ^a   Circosta, Paola ^a   Allione, Bernardino ^c   Casorzo, Laura ^a   Ghia, Paolo ^a,b   Caligaris Cappio, Federico ^a,b,d  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c C Arrigo Children's Hospital   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR VACCINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 4043126718     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.4.2855     Document Type: Article

References (39)

1. Burnett, A. K. 1999. Tailoring the treatment of acute myeloid leukemia. Curr. Opin. Oncol. 11:14.
2. Estey, E. H. 2002. New drugs for therapy of AML. Leukemia 16:306.
3. Galea-Lauri, J. 2002. Immunological weapons against acute myeloid leukaemia. Immunology 107:20.
4. Bhardwaj, N. 2001. Processing and presentation of antigens by dendritic cells: implications for vaccines. Trends Mol. Med. 7:388.
5. Stripecke, R., A. M. Levine, V. Pullarkat, and A. A. Cardoso. 2002. Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods. Leukemia 16:1974.
6. Mohty, M., D. Olive, and B. Gaugler. 2002. Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts. Leukemia 16:2197.
7. Orsini, E., and R. Foa. 2002. Dendritic cell generation for leukemia immunotherapy. Leuk. Res. 26:409.
8. Robinson, S. P., N. English, R. Jaju, L. Kearney, S. C. Knight, and C. D. Reid. 1998. The in-vitro generation of dendritic cells from blast cells in acute leukaemia. Br. J. Haematol. 103:763.
9. Choudhury, B. A., J. C. Liang, E. K. Thomas, L. Flores-Romo, Q. S. Xie, K. Agusala, S. Sutaria, I. Sinha, R. E. Champlin, and D. F. Claxton. 1999. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood 93:780.
10. + acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood 94:2048.
11. Charbonnier, A., B. Gaugler, D. Sainty, M. Lafage-Pochitaloff, and D. Olive. 1999. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur. J. Immunol. 29:2567.
12. Harrison, B. D., J. A. Adams, M. Briggs, M. L. Brereton, and J. A. Yin. 2001. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia. Blood 97:2764.
13. Woiciechowsky, A., S. Regn, H. J. Kolb, and M. Roskrow. 2001. Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia. Leukemia 15:246.
14. Bello-Fernandez, C., J. Stasakova, A. Renner, N. Carballido-Perrig, M. Koening, M. Waclavicek, O. Madjic, L. Oehler, O. Haas, J. M. Carballido, et al. 2003. Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties. Blood 101:2184.
15. Choudhury, A., J. L. Gajewski, J. C. Liang, U. Popat, D. F. Claxton, K. O. Kliche, M. Andreeff, and R. E. Champlin. 1997. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89:1133.
16. Smit, W. M., M. Rijnbeek, C. A. van Bergen, R. A. de Paus, H. A. Vervenne, M. van de Keur, R. Willemze, and J. H. Falkenburg. 1997. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum. Immunol. 53:216.
17. Dong, R., K. Cwynarski, A. Entwistle, F. Marelli-Berg, F. Dazzi, E. Simpson, J. M. Goldman, J. V. Melo, R. I. Lechler, I. Bellantuono, et al. 2003. Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration. Blood 101:3560.
18. Lechmann, M., E. Zinser, A. Golka, and A. Steinkasserer. 2002. Role of CD83 in the immunomodulation of dendritic cells. Int. Arch. Allergy Immunol. 129:113.
19. Kohler, T., R. Plettig, W. Wetzstein, M. Schmitz, M. Ritter, B. Mohr, U. Schaekel, G. Ehninger, and M. Bornhauser. 2000. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells. Stem Cells 18:139.
20. Re, F., M. Arpinati, N. Testoni, P. Ricci, C. Terragna, P. Preda, D. Ruggeri, B. Senese, G. Chirumbolo, V. Martelli, et al. 2002. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage. Exp. Hematol. 30:126.
21. Boyer, M. W., E. K. Waller, R. A. Bray, T. Unangst, T. S. Johnson, C. Phillips, I. Jurickova, E. F. Winton, and A. M. Yeager. 2000. Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells. Leukemia 14:412.
22. Panoskaltsis, N., T. J. Belanger, J. L. Liesveld, and C. N. Abboud. 2002. Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture. Leuk. Res. 26:191.
23. Brouwer, R. E., M. van der Hoorn, H. C. Kluin-Nelemans, S. van Zelderen-Bhola, R. Willemze, and J. H. Falkenburg. 2000. The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses. Hum Immunol. 61:565.
24. Narita, M., M. Takahashi, A. Liu, K. Nikkuni, T. Furukawa, K. Toba, S. Koyama, K. Takai, M. Sanada, and Y. Aizawa. 2001. Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia. Exp. Hematol. 29:709.
25. - progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res. 60:4403.
26. Roddie, P. H., Y. Horton, and M. L. Turner. 2002. Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1. Leukemia 16:84.
27. Lutz, M. B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23:445.
28. Dhodapkar, M. V., R. M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:233.
29. Jonuleit, H., A. Giesecke-Tuettenberg, T. Tuting, B. Thurner-Schuler, T. B. Stuge, L. Paragnik, A. Kandemir, P. P. Lee, G. Schuler, J. Knop, and A. H. Enk. 2001. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int. J. Cancer 93:243.
30. Mohty, M., D. Isnardon, D. Blaise, M. J. Mozziconacci, M. Lafage-Pochitaloff, F. Briere, J. A. Gastaut, D. Olive, and B. Gaugler. 2002. Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia. Leukemia 16:2267.
31. Cignetti, A., A. Vallario, I. Roato, P. Circosta, G. Strola, C. Scielzo, B. Allione, L. Garetto, F. Caligaris-Cappio, and P. Ghia. 2003. The characterization of chemokine production and chemokine receptor expression reveals possible functional crosstalks in AML blasts with monocytic differentiation. Exp. Hematol. 31:495.
32. Ghia, P., P. Transidico, J. P. Veiga, C. Schaniel, F. Sallusto, K. Matsushima, S. E. Sallan, A. G. Rolink, A. Mantovani, L. M. Nadler, and A. A. Cardoso. 2001. Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells. Blood 98:533.
33. Scheibenbogen, C., P. Romero, L. Rivoltini, W. Herr, A. Schmittel, J. C. Cerottini, T. Woelfel, A. M. Eggermont, and U. Keilholz. 2000. Quantitation of antigen-reactive T cells in peripheral blood by IFNγ-ELISPOT assay and chromium-release assay: a four-centre comparative trial. J. Immunol. Methods 244:81.
34. Reid, C. D. 1997. The dendritic cell lineage in haemopoiesis. Br. J. Haematol. 96:217.
35. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154:3821.
36. Kaser, A., S. Dunzendorfer, F. A. Offner, T. Ryan, A. Schwabegger, W. W. Cruikshank, C. J. Wiedermann, and H. Tilg. 1999. A role for IL-16 in the cross-talk between dendritic cells and T cells. J. Immunol. 163:3232.
37. Schuler, G., B. Schuler-Thurner, and R. M. Steinman. 2003. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15:138.
38. Claxton, D., and A. Choudhury. 2001. Potential for therapy with AML-derived dendritic cells. Leukemia 15:668.
39. Westers, T. M., A. G. Stam, R. J. Scheper, J. C. Regelink, A. W. Nieuwint, G. J. Schuurhuis, A. A. van de Loosdrecht, and G. J. Ossenkoppele. 2003. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia. Cancer Immunol. Immunother. 52:17.